Core Viewpoint - Shenzhen Mingyi Intelligent Manufacturing Technology Co., Ltd. has completed a C+ round of financing, which will further support the company's technological research and market expansion, consolidating its leading position in the industry [1][2]. Financing Details - The company did not disclose the funding sources or the scale of this financing round. Previously, Mingyi completed nearly 100 million yuan in a B++ round financing at the end of 2023, with investments from Tianhui Capital and Jiangsu Jinqiao Private Equity Fund among others [2]. Company Background - Mingyi was founded in 2018 by Dr. Wu Jian, an expert in high-throughput genetic diagnostics, and Professor Jingyue Ju, a renowned scientist in the field of gene sequencing. Dr. Wu holds a bachelor's degree from Peking University and a Ph.D. in genetic engineering from Columbia University [2]. Product Development - The company focuses on the research and manufacturing of upstream equipment and reagents in the gene sequencing industry. It has developed the UniSeq2000, an internationally leading desktop clinical application NGS sequencer, within four years. This device utilizes microfluidic chip technology and proprietary single-color fluorescence sequencing chemistry [3]. Product Features - The UniSeq2000 offers high accuracy, flexible throughput, simple operation, and controllable sequencing costs, meeting the detection needs of various application fields [3].